U.S., May 14 -- ClinicalTrials.gov registry received information related to the study (NCT07584525) titled 'Dexamethasone in Tick-borne Encephalitis' on April 26.
Brief Summary: The purpose of this study is to investigate the efficacy of dexamethasone in patients with tick-borne encephalitis.
Study Start Date: May 03, 2024
Study Type: INTERVENTIONAL
Condition:
Tick-Borne Encephalitis
Intervention:
DRUG: Dexametasone
dexamethasone 4 mg tid
DRUG: Saline (0.9% NaCl)
20 ml saline
Recruitment Status: RECRUITING
Sponsor: University Medical Centre Ljubljana
Information provided by (Responsible Party): Dasa Stupica, University Medical Centre Ljubljana
Disclaimer: Curated by HT Syndication....